Small Molecules
15 July 2013
Roche’s Erivedge receives conditional EU approval for treatment of advanced basal cell carcinoma11 July 2013
PROMETIC’S LEAD DRUG CANDIDATE, PBI-4050, ON TRACK TO ENTER CLINICAL TRIAL PROGRAM IN SEPTEMBER 201310 July 2013
Roche halts investigation of aleglitazar following regular safety review of phase III trial10 July 2013
New Drug Application Submitted to U.S. FDA for Ibrutinib in the Treatment of Two B-Cell Malignancies10 July 2013
GSK announces US submission for dabrafenib/trametinib combination in metastatic melanoma9 July 2013
CytRx’s Aldoxorubicin Shrinks Tumors and Prolongs Survival in Model of Human Brain Cancer9 July 2013
Cytokinetics Provides Update on BENEFIT-ALSNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports